Prot Cancer Research Results
Prot, Protein Levels: Click to Expand ⟱
| Source: |
| Type: |
Protein Levels
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Pca, |
LNCaP |
|
|
|
Bcl-xL↓, PB attenuates the expression of the apoptosis antagonist Bcl-XL, the double-strand break repair protein DNA-dependent protein kinase, the prostate progression marker caveolin -1, and the pro-angiogenic vascular endothelial growth factor
Cav1↓, PB Inhibits the Protein Expression of DNA-PK and Caveolin-1 in Prostate Cancer Cells
VEGF↓, Secretion of VEGF from Prostate Cancer Cells is Attenuated by PB
RadioS↑, PB was found to act in synergy with ionizing radiation to induce apoptosis in prostate cancer cells
chemoP↑, Moreover, butyrate may act as a chemopreventive agent against colon cancer [22]
HDAC↓, mechanism of action of butyrate and butyrate derivatives involves inhibition of the histone deacetylase activity in cells
*toxicity↓, Due to its low toxicity in vivo
Diff↑, differentiation-inducing activity towards cancer cells, PB and other butyrate derivatives have been considered as potential anticancer agents
Prot↓, Thus, our results show that PB can, like butyrate, attenuate the protein levels of Bcl-XL in prostate cancer cells.
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
Cav1↓, 1,
Cell Death ⓘ
Bcl-xL↓, 1,
Transcription & Epigenetics ⓘ
Prot↓, 1,
Proliferation, Differentiation & Cell State ⓘ
Diff↑, 1, HDAC↓, 1,
Angiogenesis & Vasculature ⓘ
VEGF↓, 1,
Drug Metabolism & Resistance ⓘ
RadioS↑, 1,
Functional Outcomes ⓘ
chemoP↑, 1,
Total Targets: 8
Pathway results for Effect on Normal Cells:
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: Prot, Protein Levels
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1243 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page